Insulin aspart Drug Profile

What is Insulin aspart?

Insulin aspart is a rapid-acting synthetic insulin analog that belongs to the class of antidiabetic medications known as insulins. It is designed to mimic the natural insulin produced by the pancreas and is primarily used to control blood glucose levels in people with diabetes mellitus. This medication begins working faster than regular human insulin, making it particularly useful for controlling blood sugar spikes that occur after meals.

Uses

Insulin aspart has several approved medical uses:

• Type 1 diabetes mellitus: Essential for blood glucose control in patients whose bodies cannot produce insulin naturally
• Type 2 diabetes mellitus: Used when oral medications alone are insufficient to maintain adequate blood glucose control
• Mealtime glucose control: Specifically designed to manage post-meal blood sugar spikes due to its rapid onset of action
• Diabetic ketoacidosis: May be used in hospital settings as part of emergency treatment for severe diabetes complications
• Gestational diabetes: Prescribed when diet and lifestyle modifications fail to control blood glucose during pregnancy

How it works

Insulin aspart works by binding to insulin receptors on muscle, fat, and liver cells, allowing these cells to absorb glucose from the bloodstream for energy or storage. The medication mimics the body’s natural insulin response but with a faster onset of action, typically beginning to work within 10-20 minutes after injection. This rapid action helps prevent the sharp rise in blood glucose that normally occurs after eating.

Side effects

Common side effects:

Submit Your Paper

• Hypoglycemia (low blood sugar)
• Injection site reactions (redness, swelling, itching)
• Weight gain
• Headache
• Upper respiratory tract infections
• Nausea
• Diarrhea
• Abdominal pain

Serious side effects requiring immediate medical attention:

• Severe hypoglycemia causing confusion, seizures, or loss of consciousness
• Severe allergic reactions including difficulty breathing or swelling of face and throat
• Hypokalemia (dangerously low potassium levels)
• Lipodystrophy (changes in fat tissue at injection sites)
• Fluid retention leading to heart failure in susceptible patients

Warnings and precautions

• Hypoglycemia risk: Patients must monitor blood glucose regularly and be aware of signs of low blood sugar, especially when skipping meals or exercising more than usual
• Kidney and liver disease: Dose adjustments may be necessary in patients with impaired kidney or liver function, as these conditions can affect insulin clearance
• Pregnancy and breastfeeding: Generally considered safe during pregnancy when diabetes management is essential, but requires careful monitoring and possible dose adjustments
• Driving and operating machinery: Hypoglycemia can impair concentration and reaction times, making these activities potentially dangerous
• Injection site rotation: Regular rotation of injection sites is essential to prevent lipodystrophy and ensure consistent absorption

Interactions

Several medications and substances can interact with insulin aspart:

• Beta-blockers: May mask symptoms of hypoglycemia and prolong recovery from low blood sugar episodes
• ACE inhibitors: Can enhance insulin sensitivity and increase the risk of hypoglycemia
• Corticosteroids: May increase blood glucose levels, requiring higher insulin doses
• Alcohol: Can cause delayed hypoglycemia, particularly when consumed without food
• Salicylates (aspirin): High doses may enhance insulin’s blood glucose-lowering effects
• Sulfonylureas: Combination use increases hypoglycemia risk and requires careful monitoring
• Thiazolidinediones: May increase fluid retention risk when used together
• Growth hormone: Can reduce insulin sensitivity, potentially requiring dose adjustments

Check interactions with the GMJ Interaction Checker

Dosage

Insulin aspart dosing is highly individualized based on blood glucose monitoring, dietary intake, and physical activity. For adults with diabetes, typical starting doses range from 0.2 to 0.6 units per kilogram of body weight per day, with mealtime doses usually representing 50-70% of total daily insulin requirements. The medication is typically injected 5-10 minutes before meals or within 20 minutes after starting a meal. Dosage adjustments should only be made under healthcare provider supervision based on regular blood glucose monitoring and hemoglobin A1C levels. Patients using insulin pumps may require different dosing calculations and pump-specific programming.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).